eli lilly glp-1 receptor agonist products launches pill, kicking off showdown with Novo Nordisk History of glucagon-like peptide-1 receptor
Description
Contact us now to start your weight loss journey!
Never assume a new vial has the same concentration as the last one
Patients on GLP-1 drugs who are experiencing a plateau may also want to talk with their doctor about considering a dose adjustment, medication switch or adding an additional drug
In March 2024, Novo Nordisk A/S stated that ozempic (semaglutide) 1.0 mg shows a 24% lower risk of kidney disease events in type 2 diabetes and chronic kidney disease in the FLOW trial
Blog Contributors: Amy Chow, Registered Dietitian Eileen Huang, BSc
Literature was reviewed for evidence of the psychological impact of AIWG
